Published in Am J Dis Child on April 01, 1983
Assessment of care of children with sickle cell disease: implications for neonatal screening programmes. BMJ (1990) 1.78
Costing model for neonatal screening and diagnosis of haemoglobinopathies. Arch Dis Child Fetal Neonatal Ed (1998) 0.78
Intervention strategies for children: a research agenda. Health Serv Res (1985) 0.77
The University of Florida sickle cell screening program for neonates: design and results. J Natl Med Assoc (1988) 0.75
Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. J Clin Oncol (1998) 2.55
Genetic screening: marvel or menace? Science (1984) 1.78
Genetic counseling for beta-thalassemia trait following health screening in a health maintenance organization: comparison of programmed and conventional counseling. Am J Hum Genet (1981) 1.44
Screening and genetic counseling for beta-thalassemia trait in a population unselected for interest: effects on knowledge and mood. Am J Hum Genet (1979) 1.39
Newborn screening for hemoglobinopathies in New York State: experience of physicians and parents of affected children. J Pediatr (1982) 1.35
Women's receptivity to testing for a genetic susceptibility to breast cancer. Am J Public Health (1995) 1.35
Prenatal screening for hemoglobinopathies. II. Evaluation of counseling. Am J Hum Genet (1991) 1.13
Screening and genetic counseling for beta-thalassemia trait in a population unselected for interest: comparison of three counseling methods. Am J Hum Genet (1984) 1.13
Molecular genetic analysis of tumors in von Recklinghausen neurofibromatosis: loss of heterozygosity for chromosome 17. Genes Chromosomes Cancer (1989) 1.13
Anhidrotic ectodermal dysplasia: predisposition to bronchial disease. Ann Intern Med (1971) 1.12
Induction of -globin synthesis in the -thalassaemia of Ferrara. Nat New Biol (1972) 1.08
Inducers of erythroid differentiation in K562 human leukemia cells. Exp Hematol (1981) 1.07
Erythroid colony formation from human fetal liver. Proc Natl Acad Sci U S A (1978) 1.06
Cystic fibrosis carrier population screening in the primary care setting. Am J Hum Genet (1996) 1.02
Prenatal hemoglobinopathy screening. IV. Follow-up of women at risk for a child with a clinically significant hemoglobinopathy. Am J Hum Genet (1991) 1.01
Genetic counseling of asymptomatic carriers in a primary care setting. The effectiveness of screening and counseling for beta-thalassemia trait. Ann Intern Med (1986) 0.94
Hemoglobin synthesis in cultures of hepatic erythroid cells from the human fetus. Proc Natl Acad Sci U S A (1979) 0.94
Family issues in a psychoeducation group for women with a BRCA mutation. Clin Genet (2002) 0.91
Variance of plasma free and esterified cholesterol in adult twins. Am J Hum Genet (1976) 0.90
Separation of malarial parasites according to age by density gradient centrifugation. J Lab Clin Med (1967) 0.89
Protein synthesis in the maturing reticulocyte. J Biol Chem (1967) 0.89
Distinction between two types of beta-thalassaemia by inducibility of the cell-free synthesis of beta-chains by nonthalassaemic soluble fraction. Nat New Biol (1972) 0.89
Multipotent human hematopoietic cell line K562: lineage-specific constitutive and inducible antigens. Leuk Res (1987) 0.88
The neurofibroma in von Recklinghausen neurofibromatosis has a unicellular origin. Am J Hum Genet (1991) 0.86
Protein synthesis in reticulocytes maturing in vivo. Nature (1965) 0.86
Newborn screening for sicle-cell disease. Benefits and burdens. N Y State J Med (1978) 0.86
Carrier screening for cystic fibrosis: test acceptance and one year follow-up. Am J Med Genet (1997) 0.86
An adult homozygous for persistent fetal hemoglobin. Ann Intern Med (1970) 0.85
Erythroleukemia manifesting delta beta-thalassemia. Hemoglobin (1983) 0.85
Pathogenesis of deficient serum alpha1-antitrypsin in the type ZZ homozygote. Biochem Genet (1974) 0.85
Alveolar cell carcinoma in identical twins. Similarity in time of onset, histochemistry, and site of metastasis. Ann Intern Med (1977) 0.85
Linkage between the MN- and Hb beta-loci? Hum Hered (1972) 0.84
Sickle hemoglobin: a specific radioimmunoassay. Blood (1974) 0.84
Toward providing parents the option of avoiding the birth of the first child with Cooley's anemia: response to hemoglobinopathy screening and counseling during pregnancy. Ann N Y Acad Sci (1985) 0.84
Regulation of K562 cell transferrin receptors by exogenous iron. J Cell Physiol (1985) 0.84
The diagnosis of beta-thalassemia trait: a review. Am J Hematol (1976) 0.84
A Lepore hemoglobin in a Rumanian family. Hum Hered (1969) 0.84
Hemoglobin S-C disease presenting as acute cor pulmonale. Am Rev Respir Dis (1968) 0.83
Incorporation of screening and genetic counseling for beta-thalassemia trait into primary health care: effects on knowledge and attitudes. Birth Defects Orig Artic Ser (1982) 0.83
Acquired hemoglobin H disease in idiopathic myelofibrosis. Am J Hematol (1979) 0.82
K562 human erythroleukemia cells demonstrate commitment. Blood (1985) 0.81
Solubilization of a reticulocyte ribosomal fraction responsible for the decline in ribosomal activity with cell maturation. Arch Biochem Biophys (1971) 0.81
K562 human leukemia cell passages differ in embryonic globin gene expression. Leuk Res (1984) 0.81
Induction of megakaryocytic characteristics in human leukemic cell line K562: polyploidy, inducers, and secretion of mitogenic activity. J Biol Regul Homeost Agents (1988) 0.80
The linkage relationships of the haemoglobin beta, delta and alpha loci with 34 genetic marker systems. Ann Hum Genet (1977) 0.80
Oncogene expression in neurofibromatosis. Ann N Y Acad Sci (1986) 0.80
Predicting immediate outcome of genetic counseling following screening. Soc Biol (1979) 0.80
Hemin preferentially stimulates synthesis of alpha-globin in K562 human erythroleukemia cells. Blood (1982) 0.79
Human lymphocyte telomerase is genetically regulated. Genes Chromosomes Cancer (1998) 0.79
Telomere-related components are coordinately synthesized during human T-lymphocyte activation. Leuk Res (1999) 0.79
High resolution analysis of hemoglobins: polyacrylamide isoelectric focusing. Biochem Med (1972) 0.79
Serm alpha-antitrypsin types: elastase inhibition versus trypsin inhibition. Hum Hered (1974) 0.78
Tumor suppressor genes and inherited predisposition to malignancy. Semin Oncol (1989) 0.78
Disappearance of ribosomes and polyribosomes during in vivo erythroid maturation. Nature (1967) 0.77
Hereditary haemorrhagic telangiectasia: aggravation by oral contraceptives? Lancet (1970) 0.77
Induction of HL60 cell differentiation by tiazofurin and its analogues: characterization and efficacy. Blood (1991) 0.77
Serum antitrypsin synthesis by the isolated perfused rat liver. Proc Soc Exp Biol Med (1975) 0.77
Demonstration of commitment by K562 human erythroleukemia cells. Prog Clin Biol Res (1985) 0.77
Regulation of the activity of heme degradative enzymes in K562 erythroleukemic cells: induction by thymidine. Exp Hematol (1987) 0.76
Sickle beta-thalassemia: identical twins differing in severity implicate nongenetic factors influencing course. Am J Hematol (1976) 0.76
Confusion about breast-cancer screening. N Engl J Med (1997) 0.75
Characteristics of the antitrypsin activity of human serum. J Clin Pathol (1973) 0.75
Prenatal screening for hemoglobinopathies. Am J Hum Genet (1991) 0.75
K562 human erythroleukemia cell variants resistant to growth inhibition by butyrate have deficient histone acetylation. Am J Hum Genet (1984) 0.75
Erythroid differentiation of K562 cells: mixed colonies as an index of delayed expression of commitment. Exp Hematol (1987) 0.75
Tetrahydrocannabinol inhibits adenyl cyclase in human leukemia cells. Life Sci (1990) 0.75
Assessment of evaluation of hospitalized pediatric patients with genetic disorders. Clin Pediatr (Phila) (1981) 0.75
Long survival in sickle-cell disease. Lancet (1973) 0.75
Drug-sensitive hemoglobinopathies. N Engl J Med (1973) 0.75
Genetic screening: whose responsibility? JAMA (1976) 0.75
Trypsin enhances erythropoiesis in vitro. J Lab Clin Med (1980) 0.75
Oncogene expression in myelopoiesis. Int J Cell Cloning (1987) 0.75
Textural differences between AA and SS blood specimens as detected by image analysis. Cytometry (1994) 0.75
Deleterious mutations of both BRCA1 and BRCA2 in three siblings. Genet Test (1998) 0.75
Enhanced polyribosome recovery from reticulocytes using heparin. Exp Cell Res (1967) 0.75
No limits to genetic inquiry. Hastings Cent Rep (1988) 0.75
Letter: Family history-taking. J Med Educ (1976) 0.75
Genetic counseling in medical practice. Alaska Med (1969) 0.75
Induction of hemoglobin synthesis in K562 cells by carbon dioxide deficiency. Int J Cell Cloning (1987) 0.75
Familial hearing loss associated with branchial fistulas. Pediatrics (1969) 0.75
The contribution of red cell morphology to the diagnosis of beta-thalassemia trait. Blood Cells (1986) 0.75
Genetics for the cardiologist. Part II: Chromosomal and polygenic inheritance and genetic counseling. Mod Concepts Cardiovasc Dis (1978) 0.75
K562 cell erythroid differentiation: requirement for a factor in fetal bovine serum. Exp Hematol (1985) 0.75
American society of human genetics (ASHG) committee reports. Am J Hum Genet (1987) 0.75
Genetic testing for breast-ovarian cancer susceptibility: a regional trial. Genet Test (1998) 0.75
Genetics for the cardiologist. Part I: mendelian inheritance. Mod Concepts Cardiovasc Dis (1978) 0.75
Hypersplenic thrombocytopenia in sickle cell-bata thalassemia. Am J Med Sci (1972) 0.75
Single-cell analysis of the relationship among transferrin receptors, proliferation, and cell cycle phase in K562 cells. Cytometry (1985) 0.75
Genetic considerations in neuromuscular diseases. Adv Neurol (1977) 0.75
Erythropoiesis in vitro: enhancement by neuraminidase. Blood (1981) 0.75
Sickle cell trait/hereditary persistence of fetal hemoglobin trait. Misdiagnosis as sickle cell anemia by newborn screening. Am J Dis Child (1979) 0.75
Issues in implementing prenatal screening for cystic fibrosis: results of a working conference. Genet Med (2001) 0.75
Erythroid induction of K562 human leukemia cells: enhancement by purines. Arch Biochem Biophys (1985) 0.75
What you should know about chromosome analysis. Alaska Med (1969) 0.75